Matthew T. Drake, MD, PhD | Authors

5150 JOURNAL CENTER BLVD NE

Articles

Bone Disease in Multiple Myeloma

December 30, 2009

Despite the significant progress that has occurred in recent decades in the treatment of many advanced malignancies, skeletal morbidity remains a major problem for patients affected by cancers that metastasize to or grow primarily within bone.[1] Thus as patients with a variety of malignancies survive longer, therapies to limit cancer-associated as well as treatment-associated skeletal complications have become increasingly important for the provision of optimal patient care.